Loading organizations...
Key people at Cobalt Ventures.
Cobalt Ventures functions as the corporate venture capital arm of Blue Cross and Blue Shield of Kansas City. It invests in entrepreneurs developing impactful solutions that deliver value and align incentives across healthcare payers, providers, and patients. The firm provides strategic capital and industry insights to bolster portfolio companies in product development, market validation, and customer acquisition.
Founded in 1999, Cobalt Ventures was established by Blue Cross and Blue Shield of Kansas City to strategically engage with innovative healthcare enterprises. David Eichler serves as President and Managing Partner, bringing extensive experience from prior venture capital leadership. Managing Partner Dipa Mehta contributes deep expertise from managing significant healthcare-focused venture funds.
Portfolio healthcare startups benefit from Cobalt Ventures' investment and strategic guidance. The firm targets the broader healthcare ecosystem by fostering solutions that reduce care costs, enhance patient engagement, and improve access to quality services. Its vision centers on continuous innovation and transformation within the healthcare sector, creating lasting value for stakeholders.
Key people at Cobalt Ventures.
Cobalt Ventures has 4 tracked investments across 4 companies. The latest tracked deal is $12.0M Series A in Handspring in June 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2025 | Handspring | $12.0M Series A | Cobalt Ventures | Arkitekt Ventures, NextView Ventures, Vamos Ventures, 25Madison, Hyde Park Angels, Newark Venture Partners |
| Apr 12, 2023 | Tonal | $130.0M Other Equity | Cobalt Ventures, Dragoneer Investment Group, Kindred Ventures, JON Owsley, Thvc | — |
| Apr 1, 2021 | Mux | $110.0M Series D | Coatue | Accel, Andreessen Horowitz, Benchmark, Bessemer Venture Partners, Bond, Matrix, ED Mathers, NextView Ventures, ONE Planet Group, Uncork Capital, Steven Sarowitz, A16z Scout Fund, Dragoneer Investment Group |
| Nov 16, 2020 | Nymbl Science | $4.0M Series A | Cobalt Ventures | — |